Abbott Laboratories stock slides 3.09% and underperforms rivals

8 articles · Updated · MarketWatch · May 8

Shares closed at $84.32 on Friday as the S&P 500 rose 0.84% and the Dow Jones Industrial Average edged up 0.02%.
Abbott lagged Johnson & Johnson, Pfizer and Merck, all of which posted smaller declines during an otherwise positive broader market session.
The stock finished 39.36% below its 52-week high of $139.06 reached on 24 June, while trading volume of 10.8 million stayed below its 50-day average.

Down nearly 40% from its high, is Dividend King Abbott Labs now a value trap or a once-in-a-decade buying opportunity?

With a $495M verdict upheld, can Abbott's pivot to cancer diagnostics save it from its mounting infant formula legal battles?